MedTrace Logo

Reducing Overdose After Release From Incarceration

NCT03902821 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2024-04-17

No results posted yet for this study

Summary

The primary objective of the ROAR project is to evaluate an Oregon Department of Corrections (ODOC) pilot program that combines the use of extended-release naltrexone (XR-NTX) and Certified Recovery Mentors pre-release with linkage to community substance use disorder treatment to prevent fatal and non-fatal opioid overdoses among female adults released from prison.

Conditions

  • Overdose, Drug

Interventions

OTHER

XR-NTX and Certified Recovery Mentor

All consented participants will be offered an injection of extended-release naltrexone 3-7 days prior to release from prison. All consented participants will also be introduced to Certified Recovery Mentors one month prior to release.

Sponsors & Collaborators

  • Oregon Department of Corrections

    collaborator UNKNOWN

  • CODA Inc.

    collaborator UNKNOWN

  • Bridgeway Recovery

    collaborator UNKNOWN

  • Health Insight

    collaborator UNKNOWN

  • Oregon State University

    collaborator OTHER

  • Oregon Health and Science University

    lead OTHER

Principal Investigators

  • Elizabeth Waddell, PhD · Oregon Health and Science University

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-17
Primary Completion
2021-07-14
Completion
2023-11-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03902821 on ClinicalTrials.gov